Provides clinically relevant safety information on pharmaceuticals, biologics, medical devices and natural health products for health care professionals.
File available for download in the following formats:
Provides clinically relevant safety information on pharmaceuticals, biologics, medical devices and natural health products for health care professionals.
File available for download in the following formats:
This monthly publication is intended primarily for healthcare professionals and includes information on pharmaceuticals, biologics, medical devices and natural health products.
File available for download in the following formats:
The purpose of this Notice of Amendment is to notify about the additions of fostamatinib, givosiran, lemborexant, luspatercept, ozanimod, trientine, and voretigene neparvovec to...
File available for download in the following formats:
The purpose of this Notice of Amendment is to notify about the additions of amifampridine, cedazuridine (when used in combination with another drug), etomidate, fedratinib,...
File available for download in the following formats:
This monthly publication is intended primarily for healthcare professionals and includes information on pharmaceuticals, biologics, medical devices and natural health products
File available for download in the following formats:
This monthly publication is intended primarily for healthcare professionals and includes information on pharmaceuticals, biologics, medical devices and natural health products
File available for download in the following formats:
This monthly publication is intended primarily for healthcare professionals and includes information on pharmaceuticals, biologics, medical devices and natural health products.
File available for download in the following formats:
This monthly publication is intended primarily for healthcare professionals and includes information on pharmaceuticals, biologics, medical devices and natural health products
File available for download in the following formats:
This monthly publication is intended primarily for healthcare professionals. It provides information on pharmaceuticals, biologics, natural and non-prescription health products,...
File available for download in the following formats:
The following is a list of health product advisories, type I recalls and summaries of completed safety reviews published in July 2023 by Health Canada.
File available for download in the following formats:
This monthly publication is intended primarily for healthcare professionals and includes information on pharmaceuticals, biologics, medical devices and natural health products
File available for download in the following formats:
The Health Product InfoWatch is a monthly publication intended primarily for healthcare professionals. It provides clinically relevant safety information on pharmaceuticals,...
File available for download in the following formats:
The Health Product InfoWatch is a monthly publication intended primarily for healthcare professionals. It provides clinically relevant safety information on pharmaceuticals,...
File available for download in the following formats:
The Health Product InfoWatch is a monthly publication intended primarily for healthcare professionals. It provides clinically relevant safety information on pharmaceuticals,...
File available for download in the following formats:
This monthly publication is intended primarily for healthcare professionals and includes information on pharmaceuticals, biologics, medical devices and natural health products
File available for download in the following formats:
This monthly publication is intended primarily for healthcare professionals and includes information on pharmaceuticals, biologics, medical devices and natural health products
File available for download in the following formats:
Health Canada has developed a series of research tools. These tools assess the extent a group of individuals are following Canada’s food guide: Healthy Eating Food Index...
File available for download in the following formats:
This document provides guidance on how fees for the right to sell drugs will be administered in accordance with the Food and Drugs Act and as stipulated in the Fees in Respect...
File available for download in the following formats:
The purpose of this notice is to advise stakeholders that Health Canada is proposing to: maintain the flexibilities and regulatory oversight provided by the Interim order...
File available for download in the following formats: